11/07/2023
3:34 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:31 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
3:15 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
4:16 PM | Celularity Inc (Issuer)
Celularity Inc (Issuer)
Sorrento Therapeutics (Reporting)
Sorrento Therapeutics, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:22 PM | Celularity Inc (Subject)
Celularity Inc (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
| Form SC 13G/A | |
10/05/2023
4:26 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:49 PM | Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
| Form SC 13D/A | |
09/26/2023
3:54 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:27 PM | Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Sorrento Therapeutics (Reporting)
Sorrento Therapeutics, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
8:51 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
4:25 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
10:20 AM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:59 PM | Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
| Form SC 13D/A | |
08/01/2023
5:01 AM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
4:23 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form POS AM | |
07/13/2023
5:26 AM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
8:49 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
4:24 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form POS AM | |
06/15/2023
8:41 AM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
8:23 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
2:16 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023
11:03 AM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
4:28 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form POS AM | |
05/08/2023
8:04 PM | Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
| Form NT 10-Q | |
